Skip to search formSkip to main contentSkip to account menu

cefodizime

Known as: (6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid 7(sup2)-(Z)-(O-methyloxime) 
A third-generation, aminothiazolyl cephalosporin for parenteral use. Cefodizime has broad-spectrum activity and is stable to most beta-lactamases.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
The study was carried out to determine the concentrations of cefodizime (single 2-g intravenous [i.v.] dose) and ceftriaxone… 
1995
1995
Among third-generation cephalosporins, cefodizime (CFDZ) has shown to modulate many functions of the host defense system against… 
Review
1990
Review
1990
Cefodizime is a 2-aminothiazolyl cephalosporin for parenteral use. Cefodizime has a bisubstituted thiothiazole moiety in position… 
1988
1988
In vitro experiments suggest that cefodizime, a new cephalosporin, causes an increase in phagocytic capacity. We therefore… 
1987
1987
The synthesis as well as in vitro antibacterial activity and pharmacokinetic behavior of cefodizime (HR 221, 1a), its analogs and… 
1984
1984
Studies concerning the activity of cefodizime (HR 221), on certain aspects of the immune response, were conducted. It was found… 
1982
1982
The in vitro activity of cefodizime (HR-221), a new cephalosporin antibiotic, was compared with the activities of selected…